M06 Diabetes Insipidus: Principles of Diagnosis and Treatment

Program: Meet-the-Professor Sessions
Clinical Session
Friday, April 1, 2016: 2:15 PM-3:00 PM
Room 107 (BCEC)
Friday, April 1, 2016: 3:30 PM-4:15 PM
Room 107 (BCEC)
Speaker:
Joseph G. Verbalis, MD, Georgetown University Medical Center, Washington, DC

Disclosures:
JGV: Ad Hoc Consultant, Ferring Pharmaceuticals, Ad Hoc Consultant, Otsuka.

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire